News
Though some cancer patients lack sufficient enzymes to metabolize capecitabine or 5-FU, many patients are not warned about the risks associated with these treatments.
Pathway metabolite ratios reveal distinctive glutamine metabolism in a subset of proliferating cells
Pathway-focused metabolite ratio-based analysis of 49 tumor and 8 normal epithelial cell lines grown in their respective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback